Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was incorporated in 2013 and is headquartered in Waltham, Massachusetts. Show More...
-
Website http://www.eloxxpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.00 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -280.0 -156.2 -102.2 -50.6 -26.2 -8.4 -5.4 -4.75 -1.45 -1.34 -1.36 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 1.0 5.0 32.0 38.0 39.0 Book Value Per Share * USD 0.12 1.43 1.13 0.65 Free Cash Flow Per Share * USD -1.36 -1.86 -1.07 Return on Assets % -88.03 -86.06 -99.42 -68.53 -71.49 -58.71 -82.2 -154.41 -124.99 -92.78 -101.8 Financial Leverage (Average) 1.9 2.01 1.87 1.21 1.6 2.02 6.72 1.16 1.18 1.63 1.79 Return on Equity % -158.54 -167.92 -193.0 -88.59 -95.2 -100.68 -228.24 -195.18 -146.83 -128.59 -174.34 Return on Invested Capital % -116.62 -106.87 -120.18 -88.59 -95.18 -100.67 -191.26 -194.83 -148.18 -90.97 -114.35 Interest Coverage -71.84 -37.83 -24.78 -492.35 -30.48 -28.28 Current Ratio 1.55 1.12 1.1 3.96 4.79 2.66 0.1 7.16 6.45 4.89 4.14 Quick Ratio 1.1 0.63 0.5 3.37 4.28 2.2 0.010 7.03 6.22 4.77 3.97 Debt/Equity 0.3 0.37